General
Methamphetamine Subcommittee Draft Reccomendations 08/23/2022
Draft Recommendation - Methamphetamine Subcommittee - Contingency Management - 2022
Draft Recommendation - Methamphetamine Subcommittee - Stimulant Treatment 2022
Draft Recommendation - Methamphetamine Subcommittee - Mobile Outreach Units 2022
The State of New Mexico should mandate insurance carriers within the state to cover
The State of New Mexico should mandate insurance carriers within the state to cover medications prescribed by physicians for stimulant use disorder that have shown to be effective, are still in trial, and have otherwise had an improved outcome in reducing the use of methamphetamines.
2022 Submitted Public Comment to the CDC Clinical Practice Guideline for Prescribing Opioids
Current Advisory Council Members List
Naloxone Standing Order for Opioid Treatment Centers/Programs
Naloxone (or other opioid antagonist) Statewide Standing Order for Registered Pharmacists
Naloxone (or other opioid antagonist) Standing Order Prescription Hardcopy
2021 Common Opioids & Side Effects
2021 Factors that increase overdose
Fentanyl test strips allow us to engage community members in recovery and extend life-saving interventions. (May 2021)
This document describes the 2015 Recommendations of the Governor’s Prescription Drug Misuse and Overdose Prevention and Pain Management Advisory Council and are intended to solidify and expand on work that has been accomplished to date.
This document describes the 2017 Recommendations of the Governor’s Prescription Drug Misuse and Overdose Prevention and Pain Management Advisory Council and are intended to solidify and expand on work that has been accomplished to date.
This document describes the 2020 Recommendations of the Governor’s Prescription Drug Misuse and Overdose Prevention and Pain Management Advisory Council and are intended to solidify and expand on work that has been accomplished to date.
This document describes the 2019 Recommendations of the Governor’s Prescription Drug Misuse and Overdose Prevention and Pain Management Advisory Council and are intended to solidify and expand on work that has been accomplished to date.
This document describes the 2018 Recommendations of the Governor’s Prescription Drug Misuse and Overdose Prevention and Pain Management Advisory Council and are intended to solidify and expand on work that has been accomplished to date.
This document describes the 2016 Recommendations of the Governor’s Prescription Drug Misuse and Overdose Prevention and Pain Management Advisory Council and are intended to solidify and expand on work that has been accomplished to date.